Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment

BACKGROUND: For patients coinfected with hepatitis C virus (HCV) and hepatitis B virus (HBV), HCV treatment with direct-acting antivirals can lead to HBV reactivation. We evaluated HBV reactivation during ledipasvir/sofosbuvir treatment and 108-week follow-up. METHODS: In Taiwan, 111 patients with H...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chun Jen, Sheen, I Shyan, Chen, Chi Yi, Chuang, Wan Long, Wang, Horng Yuan, Tseng, Kuo Chih, Chang, Ting Tsung, Yang, Jenny, Massetto, Benedetta, Suri, Vithika, Camus, Gregory, Jiang, Deyuan, Zhang, Fangqiu, Gaggar, Anuj, Hu, Tsung Hui, Hsu, Yu Chun, Lo, Gin Ho, Chu, Chi Jen, Chen, Jyh Jou, Peng, Cheng Yuan, Chien, Rong Nan, Chen, Pei Jer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427145/
https://www.ncbi.nlm.nih.gov/pubmed/34864948
http://dx.doi.org/10.1093/cid/ciab971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427145/
https://www.ncbi.nlm.nih.gov/pubmed/34864948
http://dx.doi.org/10.1093/cid/ciab971

Ejemplares similares